Details for New Drug Application (NDA): 019643
✉ Email this page to a colleague
The generic ingredient in MEVACOR is lovastatin. There are thirty-three drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the lovastatin profile page.
Summary for 019643
Tradename: | MEVACOR |
Applicant: | Merck |
Ingredient: | lovastatin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019643
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Mar 28, 1991 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 20MG **Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Aug 31, 1987 | TE: | RLD: | Yes |
Profile for product number 004
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 40MG **Federal Register notice that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 14, 1988 | TE: | RLD: | Yes |
Expired US Patents for NDA 019643
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | MEVACOR | lovastatin | TABLET;ORAL | 019643-002 | Mar 28, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Merck | MEVACOR | lovastatin | TABLET;ORAL | 019643-004 | Dec 14, 1988 | ⤷ Sign Up | ⤷ Sign Up |
Merck | MEVACOR | lovastatin | TABLET;ORAL | 019643-003 | Aug 31, 1987 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription